Thirteen states are experiencing “high” respiratory virus activity: Texas, Oklahoma, South Dakota, Minnesota, Florida, Georgia, South Carolina, Maryland, Pennsylvania, New York, Connecticut, Hawaii and Washington, D.C.
Three states are experiencing “very high” levels: New Hampshire, New Jersey and Wisconsin.
Four more updates:
- Test positivity rates for the flu have increased to 25% while COVID-19 remained steady at 6.2% and RSV positivity decreased slightly to 8.8%.
- ED visits for influenza and RSV remain elevated, with COVID-19-related visits increasing since the fall. Influenza-related ED visits continue to increase, accounting for 5.4% of all visits for the week ending Jan. 18 and up from 4.9% the previous week. In comparison, COVID-19 accounted for 0.9% of ED visits and RSV for 0.6%.
- Wastewater surveillance showed high levels of both COVID-19 and influenza A, indicating widespread activity, while RSV levels are moderate.
- The CDC forecasts that influenza-related ED visits will remain high over the coming weeks, while COVID-19 and RSV activity are expected to dip slightly. Overall, respiratory illness activity is expected to remain elevated.
- Vaccination coverage maintains a concern, with both COVID-19 and influenza vaccination rates lower than desired and RSV vaccines seeing a particularly low uptake among children and adults, according to the CDC.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
